MND and ALS are not exactly the same thing, but they often refer to the same condition depending on where you live. Motor neurone disease (MND) is an umbrella term covering several conditions that destroy the nerve cells controlling voluntary movement. Amyotrophic lateral sclerosis (ALS) is the most common form of MND, accounting for the vast majority of cases. In the UK and Australia, “MND” is the preferred term and is often used as a direct synonym for ALS. In the United States, “ALS” is the standard term, sometimes still called Lou Gehrig’s disease.
The confusion is understandable: because ALS is so dominant among MND subtypes, many doctors and organizations use the two names interchangeably. But technically, MND is the broader category, and ALS sits within it alongside several rarer conditions.
Why the Names Get Used Interchangeably
The overlap in terminology comes down to geography and prevalence. In the UK, the major charity and most clinicians use “motor neurone disease” as the default label, even when they’re specifically talking about ALS. In the US, neurologists almost always say “ALS.” Both are describing the same progressive, fatal condition in the vast majority of conversations. If you’ve been given a diagnosis of MND or ALS, you’re most likely dealing with the same disease regardless of which term your doctor used.
The distinction matters more in medical literature, where researchers need to separate ALS from the rarer MND subtypes. For everyday purposes, though, someone saying “I have MND” and someone saying “I have ALS” are nearly always describing the same condition.
What ALS Does to the Body
ALS attacks both types of motor neurons: upper motor neurons in the brain and lower motor neurons in the spinal cord and brainstem. Upper motor neurons send movement signals down from the brain. Lower motor neurons relay those signals out to the muscles. When both systems break down simultaneously, muscles weaken, stiffen, waste away, and eventually stop working entirely.
This dual involvement is what makes ALS particularly aggressive. It causes rapid loss of muscle control, progressing to paralysis. The most common cause of death is respiratory failure, which typically occurs two to five years after symptoms begin. In the US, the average time from diagnosis to death is about three years.
The Other Types of MND
ALS is the most common MND subtype, but it isn’t the only one. The other forms tend to be rarer and affect motor neurons differently.
- Primary lateral sclerosis (PLS) affects only the upper motor neurons. It causes stiffness, slowness of movement, and problems with balance and speech, but progresses more slowly than ALS. Because the damage is limited to one level of the motor neuron system, people with PLS generally have a better prognosis.
- Progressive muscular atrophy (PMA) targets only the lower motor neurons. People typically notice weakness in their hands or feet first, which then spreads. Cold temperatures can worsen symptoms. Like PLS, PMA tends to progress more slowly than classical ALS.
- Progressive bulbar palsy (PBP) damages motor neurons in the brainstem, the region controlling swallowing, speaking, and chewing. Early symptoms include slurred speech, difficulty swallowing, and weakness in the tongue and facial muscles.
The key pattern: ALS hits both upper and lower motor neurons at once, while the other subtypes predominantly affect one or the other. That dual burden is a major reason ALS progresses faster and carries a worse prognosis than PLS or PMA.
How Common Is ALS?
ALS is rare but not as rare as many people assume. Global incidence varies by region, ranging from about 0.5 new cases per 100,000 people per year in Asia to 2.4 per 100,000 in Western Europe. A large Danish study tracking cases over four decades found the rate climbing over time, reaching 4.45 per 100,000 in the most recent period (2018 to 2021). Whether this reflects genuinely rising rates or better detection and diagnosis remains an open question.
Causes and Genetics
Most ALS cases are sporadic, meaning they appear without a clear family history. Roughly 12% of cases are familial, linked to inherited genetic mutations. The most common genetic culprit is a mutation in a gene called C9orf72, which accounts for nearly 38% of familial cases and about 5% of sporadic ones. Another well-known mutation, in the SOD1 gene, is much rarer, found in under 1% of all ALS cases.
For the remaining sporadic cases, the cause is still poorly understood. Age, sex (men are affected slightly more often), and environmental exposures have all been studied, but no single clear trigger has been identified beyond genetics.
Available Treatments
No treatment can stop ALS from progressing. Two drugs are approved in the US for all people with ALS. Riluzole, available since 1995, extends survival modestly, by roughly two to three months on average. Edaravone, approved in 2017 and now available in an oral form, provides some additional benefit in slowing functional decline.
A third drug, tofersen, was approved in early 2023 specifically for people whose ALS is caused by a SOD1 gene mutation. It works by reducing the production of the harmful SOD1 protein and is delivered through injections into the spinal canal. Because SOD1 mutations account for such a small fraction of cases, tofersen applies to a narrow group of patients, but it represents an important shift toward genetically targeted treatment.
Beyond medication, much of ALS care focuses on managing symptoms and maintaining quality of life: breathing support, nutritional assistance, physical therapy, and communication aids as speech becomes difficult.
The Bottom Line on Terminology
If your doctor in the UK says “MND,” they almost certainly mean ALS. If your doctor in the US says “ALS,” they’re talking about the same disease that UK patients call MND. The umbrella term MND technically includes a few rarer conditions, but in practice, the two terms point to the same diagnosis more than 90% of the time. When reading about either term online, checking whether the source means ALS specifically or the broader group of motor neuron diseases will help you find the most relevant information.